Clinical Trial

Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2024 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ011 in the treatment of ovarian epithelial carcinoma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-03.
Status change: Not Yet Recruiting → Recruiting 2024-08-12
Trial Details
NCT Number NCT05856643
Lead Sponsor Shantou University Medical College
Collaborators: Guangdong ProCapZoom Biosciences Co., Ltd.
Conditions Ovarian Epithelial Carcinoma
Enrollment 12 participants
Start Date 2024-08-13
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-13